This week in Drug Discovery (26 – 30 January)
News round-up for 26 – 30 January by Bruno Quinney, Content Team at DDW.
This week in DDW, discoveries into Parkinson’s disease, allergies and common cancers could shape drug development. Elsewhere, why is the UK leading Europe’s biotech market?
The top stories:
Parkinson’s could be identified in the blood, study shows
Early signs of Parkinson’s disease can be identified in the blood, new research suggests.
Read more…
Genetic markers drive breast cancer drug resistance, study shows
Cancer scientists at City St George’s, University of London found a ‘molecular signature’ drives drug resistance in an aggressive type of breast cancer known as HER2-positive breast cancer.
Allergies could be treated by therapeutic target, study finds
Researchers have uncovered a new target which could help treat severe allergic diseases.
Potential tumour-suppressing gene identified in pancreatic cancer
A new study has revealed that low levels of CTDNEP1 may drive early and deadly pancreatic tumours, highlighting its role as a tumour suppressor.
UK is Europe’s leading biotech market, BIA report shows
The BioIndustry Association’s (BIA) report ‘UK biotech financing 2025’ shows the UK market claimed 30% of all European venture financing.
Read more…
